Hot Stocks
Friday, January 27, 2017
UPDATE 2-AbbVie's revenue misses as Hep C, cancer drugs drag
* Shares fall 1.25 pct to $60.50 premarket
(Adds details, shares)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment